UnitedHealth (UNH) Stock Slips 5% But Analysts Are Still Calling It a Buy – Here’s Why
TLDR
- UNH fell 5.2% in morning trading, hitting an intraday low of $378.08
- The ex-dividend date of $2.32 per share falls on September 14, adding near-term selling pressure
- Strong August jobs data has raised rate hike expectations, pressuring managed-care stocks
- CEO Patrick Conway sold 1,169 UNH stock at $390.00 on August 21, reducing his stake by 7.09%
- Analyst consensus remains “Moderate Buy” with an average price target of $456.56
UnitedHealth Group stock dropped 5.2% in morning trading on Wednesday, hitting an intraday low of $378.08 after opening near $405. The move extends a broader pullback from its 52-week high of $461.62 reached during the summer.
UnitedHealth Group Incorporated, UNH
The stock has been cooling since July, and today’s session reflects a mix of valuation concerns, macro pressure, and dividend mechanics all hitting at once.
One near-term factor is the approaching ex-dividend date. UNH will pay a $2.32 quarterly dividend, with the record date set for September 14. Dividend-capture traders exiting their positions ahead of that date are adding to the selling pressure.
… Continue reading the full article at the original source below.

